Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11622969 Subcutaneously administered anti-IL-6 receptor antibody

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
May 9, 2022
0
Date of Patent
April 11, 2023
0
Patent Application Number
17739688
0
Patent Citations
‌
US Patent 10874677 Subcutaneously administered anti-IL-6 receptor antibody
‌
US Patent 10961314 Liquid pharmaceutical composition comprising an anti-IL-6 receptor antibody
0
‌
US Patent 10022319 Stabilized antibody-containing liquid formulations
0
‌
US Patent 10034940 High concentration antibody and protein formulations
‌
US Patent 10168326 Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples
‌
US Patent 10231981 Subcutaneously administered anti-IL-6 receptor antibody for treatment of juvenile idiopathic arthritis
0
‌
US Patent 10316096 Stabilized antibody-containing formulations
0
‌
US Patent 10377794 Optimized method for antibody capturing by mixed mode chromatography
0
‌
US Patent 10501769 Method for the production of a glycosylated immunoglobulin
0
‌
US Patent 10590164 Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration
0
•••
Patent Citations Received
‌
US Patent 11667720 Subcutaneously administered anti-IL-6 receptor antibody
0
Patent Inventor Names
Xiaoping Zhang
0
Kimio Terao
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11622969
0
Patent Primary Examiner
‌
Prema M Mertz
0
CPC Code
‌
A61K 39/395
0

Find more entities like US Patent 11622969 Subcutaneously administered anti-IL-6 receptor antibody

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo